We discuss here the results from our studies demonstrating that simple translocations detected by chromosome painting can be used to reconstruct radiation doses for workers exposed within the dose limits and for individuals with past exposure. To be useful, a biomarker for exposure and risk assessment should employ an end point that is highly quantitative, stable over time, and relevant to human risk. Recent advances in chromosome staining using fluorescence in situ hybridization facilitate fast and reliable measurement of simple translocations, a type of DNA damage linked both to prior clastogenic exposure and to risk. In contrast to other biomarkers available, the frequency of simple translocations in individuals exposed to whole-body radiation is stable over time postexposure, has little interindividual variability, and can be measured accurately at low frequencies.
Introduction
Fast and reliable methods are needed to assess past radiation exposures and risk. This is particularly relevant for a large number of individuals exposed to various levels of ionizing radiation as a result of nuclear accidents such as Chernobyl, atmospheric nuclear testing prior to the early 1960s, past human experimentation by federal government agencies, the atom bombs dropped on Hiroshima and Nagasaki, various medical radiologic procedures, occupational exposures, and a variety of other radiation-related exposures for which good dosimetry information may not exist.
Over the last decade, efforts in our laboratory have been focused on the development and validation of a technology known as chromosome painting used in human exposure and risk assessment. This technology employs fluorescence in situ hybridization (FISH) with whole chromosome probes to rapidly and accurately detect chromosome abnormalities such as stable translocations in human cells. A detailed description of FISH can be found in Lucas et al. (1) and Pinkel et al. (2) . The development of this technology began at the Lawrence Livermore National Laboratory during the mid-1980s and has now developed into the method of choice worldwide for the detection of chromosome translocations in humans (1, (3) (4) (5) (6) .
Chromosome Painting Methodology
In principle, chromosomes in any cell can be stained by FISH. However, the method usually uses peripheral blood lymphocytes obtained from the individual to be evaluated. The lymphocytes are cultured and metaphase spreads are deposited on glass slides using standard cytogenetic methods (1, 7) . A cocktail of composite chromosome-specific DNA probes can be used in combination with pancentromeric probes to discriminate between translocations and dicentrics (1, 8 Much of our recent work has centered on the validation of the FISH technology for radiation-dose reconstruction and the development of the data tools required to translate a measured frequency into a dose. In vitro calibration curves provide a relationship between translocation frequency and dose, and therefore must be obtained for relevant exposure conditions. Most of these efforts have been summarized in Straume and Lucas (5) and are further expanded here.
Stability of Translocation Frequencies in Primates
Retrospective biodosimetry requires stability of chromosome translocation frequency over time. We demonstrated the stability of reciprocal translocations in blood lymphocytes in previously exposed rhesus monkeys (Macaca mulatta). Probes for human chromosomes 1 and 4 were used to paint those same chromosomes in M. mulatta with no cross-hybridization to other chromosomes (6) . As with human chromosomes, translocations between M. mulatta chromosomes 1 or 4 and any other chromosome were made distinct by the resultant bicolor derivative chromosomes.
The rhesus monkeys studied were exposed to whole-body (fully penetrating) radiation in 1965 in connection with National Aeronautics and Space Administration studies (10) . Twenty-eight years later, in 1993, near the end of the animals' life span, we performed biodosimetry on blood lymphocytes from six of the primates and compared our results with the actual doses delivered to the animals in 1965. These results (6) nearly 30 years postexposure are presented in Table 1 with the treatment dose.
Essentially all chromosome exchange aberrations observed 28 years after irradiation were translocations; only one dicentric was found compared to 230 translocations in 2700 cells scored. As expected from previous studies (1, (11) (12) (13) (14) , cells with dicentrics disappeared as these tissues repopulated. The data show very good agreement between the actual treatment dose given in 1965 and the dose estimated biodosimetrically from the translocation frequency in 1993. The biological dose estimates are within 15% of the actual doses for all six animals; for four of the six animals our biodosimetry differs by less than 5% from the given doses. As almost 30 years had elapsed since exposure, these results demonstrate a lifetime stability for reciprocal translocations in these animals. The animals in this study were procured, maintained, and used in accordance with the Animal Welfare Act and the Guide for the Care and Use ofLaboratory Animals (Institute of Laboratory Animal Resources, National Research Council).
Human Studies with Known Dose
The stability of reciprocal translocation frequencies in primates suggests that one should be able to reconstruct the dose to humans exposed to ionizing radiation in the past. In our laboratory we evaluated four individuals previously exposed to penetrating whole-body radiation either accidentally or during normal work situations. Each of the four cases was exposed to different types of radiation, patterns of exposure, and dose rates, but all had in common exceptionally good independent dosimetry against which our biodosimetry results could be compared. Case 1 A U.S. Department of Energy (U.S. DOE) radiation worker occupationally exposed within the DOE dose limits of 0.05 Sv/year during the 1950s, 1960s, and early 1970s was also evaluated biodosimetrically using four different assays, including 
Summary of Case Studies
Altogether, these case studies suggest that the frequency of reciprocal translocations in human lymphocytes provides an accurate measure of prior exposure to ionizing radiation in whole-body exposed individuals regardless of the temporal pattern of the exposure or the types of radiation involved. Additional individuals with good independent dosimetry are being sought to continue these very important validation studies. These data are listed in 10 for sparsely ionizing radiation (X-and gamma-rays). S ratio measurements are simple to conduct because incomplete translocations are as easy to measure as complete translocations, occur in abundance for high-LET radiation, and are measured using the same methods. Moreover, the large difference in S ratios should be sufficient to separate the high-and low-LET effect contributions in mixed radiation exposures such as the exposure received by A-bomb survivors. Importantly, such a distinctive clastogenic signature should facilitate a method to provide a causal connection between early exposure to densely ionizing radiation and late development of cancer.
Conclusion
Available biodosimetry data from human case studies together with the results for nonhuman primates provide a strong basis for the use of chromosome translocations detected by FISH to reconstruct radiation dose, regardless of when the exposure occurred or whether the exposure was received acutely or chronically.
